FibroBiologics
FBLG
53 hedge funds and large institutions have $3.28M invested in FibroBiologics in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 13 closing their positions.
2.14% less ownership
Funds ownership: 15.02% → 12.88% (-2.1%)
7% less funds holding
Funds holding: 57 → 53 (-4)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
41% less capital inflows, than outflows
Capital inflows: $509K | Capital outflows: $860K
55% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 20
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Landscape Capital Management
Englewood,
New Jersey
|
+$210K |
| 2 |
GTS Securities
Miami,
Florida
|
+$185K |
| 3 |
Renaissance Technologies
New York
|
+$35.8K |
| 4 |
&Partners
Nashville,
Tennessee
|
+$18K |
| 5 |
Luminus Management
Houston,
Texas
|
+$15.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Yorkville Advisors Global
Mountainside,
New Jersey
|
-$200K |
| 2 |
BlackRock
New York
|
-$186K |
| 3 |
Goldman Sachs
New York
|
-$72.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$66K |
| 5 |
Jane Street
New York
|
-$59.8K |
FBLG Hedge Fund Activity: Q3 2025 in Review
53 of the 7,657 institutional investors tracked by Wall St. Rank reported a position in FibroBiologics (FBLG) for Q3 2025, worth a combined $3.28M — down 12% from $3.75M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of FBLG and 9 opened new positions — a net loss of 4 holders — while 20 trimmed existing stakes and 9 added.
The largest buyer was Landscape Capital Management, opening a new position worth an estimated $210K. The largest seller was Yorkville Advisors Global, cutting an estimated $200K.
- 53 institutional investors held FibroBiologics (FBLG) as of Q3 2025, down from 57 in Q2 2025.
- Funds reported $3.28M of FibroBiologics stock for Q3 2025, down 12% quarter-over-quarter.
- 9 funds opened new FibroBiologics positions in Q3 2025 and 13 closed out, a net change of -4 holders.
- The largest FibroBiologics buyer in Q3 2025 was Landscape Capital Management, an estimated $210K added.
- The largest FibroBiologics seller in Q3 2025 was Yorkville Advisors Global, an estimated $200K sold.
Based on aggregated 13F filings for Q3 2025.